Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells.
Acta Pharmacol Sin
; 43(9): 2419-2428, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-35031699
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Tumor Suppressor Protein p53
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Acta Pharmacol Sin
Journal subject:
FARMACOLOGIA
Year:
2022
Type:
Article
Affiliation country:
United States